Turn recording back on
In vitro studies on the modification of low-dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and estradiol.
Hermann RM, Wolff HA, Jarry H, Thelen P, Gruendker C, Rave-Fraenk M, Schmidberger H, Christiansen H.
Radiat Oncol. 2008 Jul 14;3:19.
PMID: 18625043 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene.
Cao F, Jin TY, Zhou YF.
Biomed Environ Sci. 2006 Feb;19(1):35-41.
PMID: 16673816 [PubMed - indexed for MEDLINE]
Related Articles
Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro.
Hermann RM, Fest J, Christiansen H, Hille A, Rave-Fränk M, Nitsche M, Gründker C, Viereck V, Jarry H, Schmidberger H.
Strahlenther Onkol. 2007 Apr;183(4):195-202.
PMID: 17406801 [PubMed - indexed for MEDLINE]
Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.
Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S, Hursting SD.
Mol Carcinog. 2000 Oct;29(2):92-102.
PMID: 11074606 [PubMed - indexed for MEDLINE]
A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL, Capodice JL, Desai M, Buttyan R, Katz AE.
Clin Cancer Res. 2004 Aug 1;10(15):5282-92.
PMID: 15297432 [PubMed - indexed for MEDLINE]
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM, LaSpina M, Long J, Ho SM.
Cancer Res. 2000 Jun 15;60(12):3175-82.
PMID: 10866308 [PubMed - indexed for MEDLINE]
Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.
Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG.
BMC Cancer. 2006 Apr 26;6:107.
PMID: 16640785 [PubMed - indexed for MEDLINE]
Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta.
Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H.
Eur Urol. 2004 Feb;45(2):245-51; discussion 251.
PMID: 14734014 [PubMed - indexed for MEDLINE]
Combination of genistein with ionizing radiation on androgen-independent prostate cancer cells.
Yan SX, Ejima Y, Sasaki R, Zheng SS, Demizu Y, Soejima T, Sugimura K.
Asian J Androl. 2004 Dec;6(4):285-90.
PMID: 15546018 [PubMed - indexed for MEDLINE]
Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA, Krebiehl G, Dittmann K, Kehlbach R, Rodemann HP.
Radiother Oncol. 2007 Feb;82(2):229-38. Epub 2007 Jan 4.
PMID: 17207548 [PubMed - indexed for MEDLINE]
Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
Robertson CN, Roberson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS, Fine RL.
J Natl Cancer Inst. 1996 Jul 3;88(13):908-17.
PMID: 8656443 [PubMed - indexed for MEDLINE]
[Enhancing effect of isoflavonoid genistein on radiosensitivity of DU145 prostate cancer cells]
Yan SX, Zheng SS.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 May;33(3):239-44. Chinese.
PMID: 15179686 [PubMed - indexed for MEDLINE]
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line.
Davis DA, Sarkar SH, Hussain M, Li Y, Sarkar FH.
BMC Cancer. 2006 Jan 24;6:22.
PMID: 16433906 [PubMed - indexed for MEDLINE]
Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K, Müller SA, Seidl C, Grosu AL, Schwaiger M, Senekowitsch-Schmidtke R.
Strahlenther Onkol. 2008 Jun;184(6):319-24.
PMID: 18535808 [PubMed - indexed for MEDLINE]
No supra-additive effects of goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro.
Hermann RM, Schwarten D, Fister S, Grundker C, Rave-Frank M, Nitsche M, Hille A, Thelen P, Schmidberger H, Christiansen H.
Radiat Oncol. 2007 Aug 26;2:31.
PMID: 17718927 [PubMed - in process]
Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
Woynarowska BA, Roberts K, Woynarowski JM, MacDonald JR, Herman TS.
Radiat Res. 2000 Oct;154(4):429-38.
PMID: 11023607 [PubMed - indexed for MEDLINE]
Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
Cancer Res. 2000 Dec 1;60(23):6630-40.
PMID: 11118046 [PubMed - indexed for MEDLINE]
In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS.
Cancer. 1996 May 1;77(9):1862-72.
PMID: 8646686 [PubMed - indexed for MEDLINE]
Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR, Sutherland RL.
Cancer Res. 1987 Oct 15;47(20):5323-9.
PMID: 3652038 [PubMed - indexed for MEDLINE]
Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH, Burnstein KL.
Endocrinology. 1998 Mar;139(3):1197-207.
PMID: 9492054 [PubMed - indexed for MEDLINE]